Anjali Singh

Tata Passenger Electric Mobility plans five new EV models by FY30 and Rs 16,000-18,000 crore capex on products, technology and charging infrastructure as Tata EV sales cross 250,000 units

HN Reliance Foundation Hospital has launched a tele-robotic surgery programme, allowing Mumbai surgeons to remotely perform, guide robotic procedures at a Jamnagar partner centre using Jio's network

Cipla has launched Afrezza, an inhaled rapid-acting insulin for adults with diabetes, after CDSCO approval, and plans an awareness drive on insulin adherence

As GLP-1 competition heats up, Emcure is pricing semaglutide brand Poviztra at ₹8,790 a month and targeting demand beyond metros with deeper distribution in smaller cities

Founded in 2006, Sensa Core operates in the design, development, manufacturing and distribution of specialised in-vitro diagnostic (IVD) devices

Wholesales jump 19 per cent in November even as retail sales soften

Cipla will exclusively market five Pfizer brands in India, adding ₹400-430 crore of established acute therapies to its portfolio without manufacturing risk

Sun Pharma's Baska plant in Gujarat receives OAI status from the US FDA after inspection, adding near-term regulatory uncertainty but not impacting current US supplies

Scheduled for launch in early 2026, the Gravite will be locally manufactured at Renault-Nissan's Chennai plant and is the first model under Nissan's refreshed India strategy

Tata Motors said the new-generation Sierra logged 70,000 confirmed bookings in 24 hours, with deliveries set from January 15, 2026, and prices ranging from Rs 11.49 lakh

Sales volumes rose 7.2 per cent year-on-year in October 2025 to 19,555 units, before moderating by 1.4 per cent in November to 10,396 units

Planning mid-cycle facelifts over new launches

This optimistic outlook builds on the fact that Swedish companies invested a total of $2.5 bn in India over the last six years, highlighting the expanding economic corridor between the two nations

Sector optimistic that 'supportive policy reforms' will continue, says group

The company said the euro-INR exchange rate has stayed above the Rs 100 mark through 2025, well above historical averages, significantly raising its cost base

forex pressures, rising commodity prices, rural demand uncertainty to push prices up

Zydus will commercialise FYB206 in North America, while Formycon will lead development, regulatory filings and supply, with a US FDA filing expected soon

The JV plans to commercialise 18 semiochemical and pheromone technologies developed by ATGC Biotech in multiple international markets, including Israel, Brazil, Australia and countries in Africa

Indian automakers are reviving legacy nameplates to leverage brand recall and stand out in a crowded market, as classic badges like Sierra, Safari, Baleno and Scorpio return to attract buyers

ASG Eye Hospital will invest Rs 2,000 crore to expand from 175-plus centres to 600-700 by 2030, using acquisitions, new hospitals and district centres, backed by investors